期刊文献+

人类白细胞抗原G在口腔鳞癌中的表达及意义

Expression and clinical significance of human leucocyte antigen protein G in oral squamous cell carcinoma
原文传递
导出
摘要 目的:检测口腔鳞癌组织中人类白细胞抗原G(HLA-G)的表达,探讨其在口腔鳞癌发生发展中的意义。方法:采用免疫组织化学法检测48例口腔鳞癌癌巢及癌旁组织,20例正常口腔黏膜中HLA-G的表达情况,探究分析与病理参数之间的相关性。结果:HLA-G分子在口腔鳞癌组织中的阳性表达率为70.8%(34/48),在癌旁组织中为8.3%(4/48),而在正常口腔黏膜组织中无表达(0/20)。HLA-G分子表达与有无淋巴结转移有显著相关性(P=0.005),但其与年龄及肿瘤分化程度等多项病理参数并无相关性(P>0.05)。结论:HLA-G分子在口腔鳞状细胞癌组织中表达明显高于癌旁及正常口腔黏膜组织,HLA-G分子促进了口腔鳞状细胞癌的发生发展。HLA-G分子与口腔鳞癌发生发展密切相关。 Objective:To explore and analyze the expression of human leukocyte antigen G(HLA-G)in oral squamous cell carcinoma(OSCC),and to confirm the correlation between HLA-G and OSCC.Methods:The expression of HLA-G in 48 cases of oral squamous cell carcinoma nests and adjacent tissues,and 20 cases of normal oral mucosa were detected by immunohistochemistry.Results:The positive expression rate of HLA-G was 70.8%(34/48)in OSCC and 8.3%(4/48)in paracancerous tissues,but no expression in normal oral mucosa(0/20).There was a significant correlation between HLA-G expression and lymph node metastasis(P=0.005),but there was no significant correlation between HLA-G expression and age and tumor differentiation(P>0.05).Conclusion:The expression of HLA-G in OSCC is significantly higher than that in adjacent OSCC and normal oral mucosa.HLA-G molecule promotes the occurrence and development of OSCC.It’s closely related to the occurrence and development of OSCC.
作者 何晶 郑玲玲 HE Jing;ZHENG Ling-ling(Department of Stomatology,Jingnien No.2 People's Hospitaly Hubei Jingmen 448000,China;Department of Pothology,Jingnien No.2 People's Hospitaly Hubei Jingmen 448000,China)
出处 《临床口腔医学杂志》 2021年第9期523-526,共4页 Journal of Clinical Stomatology
关键词 人类白细胞抗原G 口腔鳞状细胞癌 免疫组织化学 Human leucocyte antigen G Oral squamous cell cacinoma Immunohistochemistry
  • 相关文献

参考文献4

二级参考文献20

  • 1颜卫华,林爱芬,范丽安.HLA-G α1结构域Met^(76)和Gln^(79)在KIR2DL4特异性识别中的作用研究[J].中华微生物学和免疫学杂志,2006,26(10):875-878. 被引量:2
  • 2Crum C P,Lee K R.妇产科诊断病理学[M]∥回允中,译.北京:北京大学医学出版社,2007:623.
  • 3McMeekin S, Patel R, Verschraegen C, et al. Phase I/II study of sagopilone(ZK-EPO)plus carboplatin in women with recurrent platinum-sensitive ovarian cancer[J]. Br J Cancer, 2012,106(1):70-6.
  • 4Paul P, Rouas-Freiss N, Khalil-Daher I, et al. HLA-G expression in melanoma: a way for tumor cells to escape from immune surveillance[J]. Proc Natl Acad Sci USA, 1998,95(8):4510-5.
  • 5Kurman R J, Carcangiu M L, Herrington C S, et al. WHO classification of tumours of female reproductive organs[M]. 4th ed. Lyon: IARC Press, 2014:21-4.
  • 6Malpica A, Deavers M T, Lu K, et al. Grading ovarian serous carcinoma using a two-tier system [J]. Am J Surg Pathol, 2004, 28(4):496-504.
  • 7Wong K K, Lu K H, Malpica A, et al. Significantly greater expression of ER, PR and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis [J]. Int J Gynecol Pathol, 2007,26(4):404-9.
  • 8Kurman R J, Shih I M. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer. Shifting the paradigm[J]. Hum Pathol, 2011,42(7):918-31.
  • 9Cirulli V, Zalatan J, McMaster M, et al. The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G[J]. Diabetes, 2006,55(5):1214-22.
  • 10Menier C, Guillard C, Cassinat B, et al. HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera[J]. Leukemia, 2008,22(3):578-84.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部